drugset / Trial / NCT05720494
A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
Treatments for narcolepsy and hypersomnolence disorders should have good oral bioavailability and brain penetration properties. JZP441 has demonstrated wake-promoting efficacy and anticataplectic activity in nonclinical studies and may represent a novel approach for these patients.
Timeline
- Start
- 2023-01-26
- Primary completion
- 2023-09-29
- Completion
- 2023-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JZP441 | Unknown | — | Oral |
Indications
No indication recorded.